Viewing Study NCT02410356


Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2025-12-25 @ 9:01 PM
Study NCT ID: NCT02410356
Status: TERMINATED
Last Update Posted: 2021-12-10
First Post: 2015-03-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module